Your browser doesn't support javascript.
loading
Letter: faecal calprotectin for the prediction of relapse in inactive inflammatory bowel disease - authors' reply.
Zhulina, Y; Cao, Y; Amcoff, K; Carlson, M; Tysk, C; Halfvarson, J.
Affiliation
  • Zhulina Y; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. yaroslava.zhulina@regionorebrolan.se.
  • Cao Y; Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.
  • Amcoff K; Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Carlson M; Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Tysk C; Department of Medical Sciences, Gastroenterology Research Group, Uppsala University, Uppsala, Sweden.
  • Halfvarson J; Department of Medical Sciences, Gastroenterology Research Group, Uppsala University, Uppsala, Sweden.
Aliment Pharmacol Ther ; 44(7): 770-1, 2016 10.
Article in En | MEDLINE | ID: mdl-27593429
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Leukocyte L1 Antigen Complex Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2016 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Inflammatory Bowel Diseases / Leukocyte L1 Antigen Complex Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2016 Type: Article